Clinical trial
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes…
NCT00233142 · Syracuse University, Other · Completed
Key facts
| NCT number | NCT00233142 |
|---|---|
| Title | Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients |
| Official title | Expressive Writing: Complementary Treatment for Diabetes |
| Lead sponsor | Syracuse University, Other |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Stress, Depression |
| Intervention type | Behavioral |
| Interventions | Expressive writing, Neutral writing |
| Enrollment | 187 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Oct 5, 2005 |
| Last update posted | Apr 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: